TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism

Alzheimer's disease (AD) is the leading cause of age-related dementia among the elderly population. Recent genetic studies have identified rare variants of the gene encoding the triggering receptor expressed on myeloid cells-2 (TREM2) as significant genetic risk factors in late-onset AD (LOAD)....

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in aging neuroscience 2018-11, Vol.10, p.395-395
Main Authors: Zheng, Honghua, Cheng, Baoying, Li, Yanfang, Li, Xin, Chen, Xiaofen, Zhang, Yun-Wu
Format: Article
Language:English
Subjects:
Age
Aging
Alzheimer's disease
Amyloid
Brain research
Dementia
Dementia disorders
Disease
Energy metabolism
Geriatrics
Metabolism
Microglia
Myeloid cells
Neuroscience
Pathogenesis
Pathology
Peptides
Population genetics
Population studies
Proteins
Risk factors
Roles
Senile plaques
survival
Tau protein
TREM2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503
cites cdi_FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503
container_end_page 395
container_issue
container_start_page 395
container_title Frontiers in aging neuroscience
container_volume 10
creator Zheng, Honghua
Cheng, Baoying
Li, Yanfang
Li, Xin
Chen, Xiaofen
Zhang, Yun-Wu
description Alzheimer's disease (AD) is the leading cause of age-related dementia among the elderly population. Recent genetic studies have identified rare variants of the gene encoding the triggering receptor expressed on myeloid cells-2 (TREM2) as significant genetic risk factors in late-onset AD (LOAD). TREM2 is specifically expressed in brain microglia and modulates microglial functions in response to key AD pathologies such as amyloid-β (Aβ) plaques and tau tangles. In this review article, we discuss recent research progress in our understanding on the role of TREM2 in microglia and its relevance to AD pathologies. In addition, we discuss evidence describing new TREM2 ligands and the role of TREM2 signaling in microglial survival and energy metabolism. A comprehensive understanding of TREM2 function in the pathogenesis of AD offers a unique opportunity to explore the potential of this microglial receptor as an alternative target in AD therapy.
doi_str_mv 10.3389/fnagi.2018.00395
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b3e5afc45d7f446d858f7fa6783e2864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b3e5afc45d7f446d858f7fa6783e2864</doaj_id><sourcerecordid>2300633075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503</originalsourceid><addsrcrecordid>eNpdkc9rFDEUx4MottTePcmAB3vZ9eX3jAeh1G0tdBG0nkNmkkyzZCY1mVmof33T3Vpac8nj5fu-fPM-CL3HsKS0bj67Ufd-SQDXSwDa8FfoEAtBF4wK_vpZfYCOc95AOZQC8PotOqDAKZHADtHF9c_VmlR-rE7D3xvrB5s-5eqbz1Zn-6Va-y7FPngdql9z2vptKfRoqtVoU39Xre2k2xh8Ht6hN06HbI8f7yP0-3x1ffZ9cfXj4vLs9GrRsQamhelsowmRtTCtKImYbDQWmhkqQErZEMeIwxJLS2vGnGukM-CcaQGE1RzoEbrc-5qoN-o2-UGnOxW1V7tGTL3SafJdsKqllmvXMW6kY0yYmtdOOi1kTS2pBSteX_det3M72BJtnJIOL0xfvoz-RvVxqwQRnGJSDE4eDVL8M9s8qcHnzoagRxvnrAjmHAtggIv043_STZzTWFalSKEiChrJiwr2qrL1nJN1T2EwqAfoagddPUBXO-hl5MPzTzwN_ENM7wHjdaan</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2300633075</pqid></control><display><type>article</type><title>TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Zheng, Honghua ; Cheng, Baoying ; Li, Yanfang ; Li, Xin ; Chen, Xiaofen ; Zhang, Yun-Wu</creator><creatorcontrib>Zheng, Honghua ; Cheng, Baoying ; Li, Yanfang ; Li, Xin ; Chen, Xiaofen ; Zhang, Yun-Wu</creatorcontrib><description>Alzheimer's disease (AD) is the leading cause of age-related dementia among the elderly population. Recent genetic studies have identified rare variants of the gene encoding the triggering receptor expressed on myeloid cells-2 (TREM2) as significant genetic risk factors in late-onset AD (LOAD). TREM2 is specifically expressed in brain microglia and modulates microglial functions in response to key AD pathologies such as amyloid-β (Aβ) plaques and tau tangles. In this review article, we discuss recent research progress in our understanding on the role of TREM2 in microglia and its relevance to AD pathologies. In addition, we discuss evidence describing new TREM2 ligands and the role of TREM2 signaling in microglial survival and energy metabolism. A comprehensive understanding of TREM2 function in the pathogenesis of AD offers a unique opportunity to explore the potential of this microglial receptor as an alternative target in AD therapy.</description><identifier>ISSN: 1663-4365</identifier><identifier>EISSN: 1663-4365</identifier><identifier>DOI: 10.3389/fnagi.2018.00395</identifier><identifier>PMID: 30532704</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Age ; Aging ; Alzheimer's disease ; Amyloid ; Brain research ; Dementia ; Dementia disorders ; Disease ; Energy metabolism ; Geriatrics ; Metabolism ; Microglia ; Myeloid cells ; Neuroscience ; Pathogenesis ; Pathology ; Peptides ; Population genetics ; Population studies ; Proteins ; Risk factors ; Roles ; Senile plaques ; survival ; Tau protein ; TREM2</subject><ispartof>Frontiers in aging neuroscience, 2018-11, Vol.10, p.395-395</ispartof><rights>2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2018 Zheng, Cheng, Li, Li, Chen and Zhang. 2018 Zheng, Cheng, Li, Li, Chen and Zhang</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503</citedby><cites>FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2300633075/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2300633075?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,25736,27907,27908,36995,36996,44573,53774,53776,74877</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30532704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Honghua</creatorcontrib><creatorcontrib>Cheng, Baoying</creatorcontrib><creatorcontrib>Li, Yanfang</creatorcontrib><creatorcontrib>Li, Xin</creatorcontrib><creatorcontrib>Chen, Xiaofen</creatorcontrib><creatorcontrib>Zhang, Yun-Wu</creatorcontrib><title>TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism</title><title>Frontiers in aging neuroscience</title><addtitle>Front Aging Neurosci</addtitle><description>Alzheimer's disease (AD) is the leading cause of age-related dementia among the elderly population. Recent genetic studies have identified rare variants of the gene encoding the triggering receptor expressed on myeloid cells-2 (TREM2) as significant genetic risk factors in late-onset AD (LOAD). TREM2 is specifically expressed in brain microglia and modulates microglial functions in response to key AD pathologies such as amyloid-β (Aβ) plaques and tau tangles. In this review article, we discuss recent research progress in our understanding on the role of TREM2 in microglia and its relevance to AD pathologies. In addition, we discuss evidence describing new TREM2 ligands and the role of TREM2 signaling in microglial survival and energy metabolism. A comprehensive understanding of TREM2 function in the pathogenesis of AD offers a unique opportunity to explore the potential of this microglial receptor as an alternative target in AD therapy.</description><subject>Age</subject><subject>Aging</subject><subject>Alzheimer's disease</subject><subject>Amyloid</subject><subject>Brain research</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Disease</subject><subject>Energy metabolism</subject><subject>Geriatrics</subject><subject>Metabolism</subject><subject>Microglia</subject><subject>Myeloid cells</subject><subject>Neuroscience</subject><subject>Pathogenesis</subject><subject>Pathology</subject><subject>Peptides</subject><subject>Population genetics</subject><subject>Population studies</subject><subject>Proteins</subject><subject>Risk factors</subject><subject>Roles</subject><subject>Senile plaques</subject><subject>survival</subject><subject>Tau protein</subject><subject>TREM2</subject><issn>1663-4365</issn><issn>1663-4365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc9rFDEUx4MottTePcmAB3vZ9eX3jAeh1G0tdBG0nkNmkkyzZCY1mVmof33T3Vpac8nj5fu-fPM-CL3HsKS0bj67Ufd-SQDXSwDa8FfoEAtBF4wK_vpZfYCOc95AOZQC8PotOqDAKZHADtHF9c_VmlR-rE7D3xvrB5s-5eqbz1Zn-6Va-y7FPngdql9z2vptKfRoqtVoU39Xre2k2xh8Ht6hN06HbI8f7yP0-3x1ffZ9cfXj4vLs9GrRsQamhelsowmRtTCtKImYbDQWmhkqQErZEMeIwxJLS2vGnGukM-CcaQGE1RzoEbrc-5qoN-o2-UGnOxW1V7tGTL3SafJdsKqllmvXMW6kY0yYmtdOOi1kTS2pBSteX_det3M72BJtnJIOL0xfvoz-RvVxqwQRnGJSDE4eDVL8M9s8qcHnzoagRxvnrAjmHAtggIv043_STZzTWFalSKEiChrJiwr2qrL1nJN1T2EwqAfoagddPUBXO-hl5MPzTzwN_ENM7wHjdaan</recordid><startdate>20181123</startdate><enddate>20181123</enddate><creator>Zheng, Honghua</creator><creator>Cheng, Baoying</creator><creator>Li, Yanfang</creator><creator>Li, Xin</creator><creator>Chen, Xiaofen</creator><creator>Zhang, Yun-Wu</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20181123</creationdate><title>TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism</title><author>Zheng, Honghua ; Cheng, Baoying ; Li, Yanfang ; Li, Xin ; Chen, Xiaofen ; Zhang, Yun-Wu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Aging</topic><topic>Alzheimer's disease</topic><topic>Amyloid</topic><topic>Brain research</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Disease</topic><topic>Energy metabolism</topic><topic>Geriatrics</topic><topic>Metabolism</topic><topic>Microglia</topic><topic>Myeloid cells</topic><topic>Neuroscience</topic><topic>Pathogenesis</topic><topic>Pathology</topic><topic>Peptides</topic><topic>Population genetics</topic><topic>Population studies</topic><topic>Proteins</topic><topic>Risk factors</topic><topic>Roles</topic><topic>Senile plaques</topic><topic>survival</topic><topic>Tau protein</topic><topic>TREM2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Honghua</creatorcontrib><creatorcontrib>Cheng, Baoying</creatorcontrib><creatorcontrib>Li, Yanfang</creatorcontrib><creatorcontrib>Li, Xin</creatorcontrib><creatorcontrib>Chen, Xiaofen</creatorcontrib><creatorcontrib>Zhang, Yun-Wu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in aging neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Honghua</au><au>Cheng, Baoying</au><au>Li, Yanfang</au><au>Li, Xin</au><au>Chen, Xiaofen</au><au>Zhang, Yun-Wu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism</atitle><jtitle>Frontiers in aging neuroscience</jtitle><addtitle>Front Aging Neurosci</addtitle><date>2018-11-23</date><risdate>2018</risdate><volume>10</volume><spage>395</spage><epage>395</epage><pages>395-395</pages><issn>1663-4365</issn><eissn>1663-4365</eissn><abstract>Alzheimer's disease (AD) is the leading cause of age-related dementia among the elderly population. Recent genetic studies have identified rare variants of the gene encoding the triggering receptor expressed on myeloid cells-2 (TREM2) as significant genetic risk factors in late-onset AD (LOAD). TREM2 is specifically expressed in brain microglia and modulates microglial functions in response to key AD pathologies such as amyloid-β (Aβ) plaques and tau tangles. In this review article, we discuss recent research progress in our understanding on the role of TREM2 in microglia and its relevance to AD pathologies. In addition, we discuss evidence describing new TREM2 ligands and the role of TREM2 signaling in microglial survival and energy metabolism. A comprehensive understanding of TREM2 function in the pathogenesis of AD offers a unique opportunity to explore the potential of this microglial receptor as an alternative target in AD therapy.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>30532704</pmid><doi>10.3389/fnagi.2018.00395</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-4365
ispartof Frontiers in aging neuroscience, 2018-11, Vol.10, p.395-395
issn 1663-4365
1663-4365
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b3e5afc45d7f446d858f7fa6783e2864
source Publicly Available Content Database; PubMed Central
subjects Age
Aging
Alzheimer's disease
Amyloid
Brain research
Dementia
Dementia disorders
Disease
Energy metabolism
Geriatrics
Metabolism
Microglia
Myeloid cells
Neuroscience
Pathogenesis
Pathology
Peptides
Population genetics
Population studies
Proteins
Risk factors
Roles
Senile plaques
survival
Tau protein
TREM2
title TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A49%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TREM2%20in%20Alzheimer's%20Disease:%20Microglial%20Survival%20and%20Energy%20Metabolism&rft.jtitle=Frontiers%20in%20aging%20neuroscience&rft.au=Zheng,%20Honghua&rft.date=2018-11-23&rft.volume=10&rft.spage=395&rft.epage=395&rft.pages=395-395&rft.issn=1663-4365&rft.eissn=1663-4365&rft_id=info:doi/10.3389/fnagi.2018.00395&rft_dat=%3Cproquest_doaj_%3E2300633075%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-dce9a22786db6000479a16a4d36077792f42f1717e3844ff97fd0ffdb006ea503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2300633075&rft_id=info:pmid/30532704&rfr_iscdi=true